Dexmedetomidine: Therapeutic Use for the Termination of Reentrant Supraventricular Tachycardia

Congenital Heart Disease

Volumn 8, Issue 1, 2013, Pages 48-56

  Chrysostomou, Constantinos ^a   Morell, Victor O ^a   Wearden, Peter ^a   Sanchez de Toledo, Joan ^b   Jooste, Edmund H ^c   Beerman, Lee ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c DUKE CHILDREN S HOSPITAL   (United States)

Author keywords

Adenosine; Adrenergic agonists; Arrhythmias; Cardioversion; Dexmedetomidine; Supraventricular tachycardia

Indexed keywords

ADENOSINE; DEXMEDETOMIDINE;

AGITATION; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CARDIOVERSION; CLINICAL ARTICLE; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MALE; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; CHILD, PRESCHOOL; DEXMEDETOMIDINE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; RETROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84873033647     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00669.x     Document Type: Article

References (22)

1. Blomström-Lundqvist C, Scheinman MM, Aliot EM, etal. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias). Circulation. 2003;108:1871-1909.
2. Riccardi A, Arboscello E, Ghinatti M, Minuto P, Lerza R. Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002-2006). Am J Emerg Med. 2008;26:879-882.
3. Harvey MG, Safih S, Wallace M. Adenosine-induced complete heart block: not so transient. Emerg Med Australas. 2007;19:559-562.
4. Watanabe S, Kono Y, Kaneko S, Kano T. Effects of a bolus injection of adenosine triphosphate on AV conduction and hemodynamics in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 1999;13:181-185.
5. Cairns CB, Niemann JT. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20:717-721.
6. Kirk CR, Gibbs JL, Thomas R, Radley-Smith R, Qureshi SA. Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child. 1987;62:1265-1266.
7. Garland JS, Berens RJ, Losek JD, Wilson AD. An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. Pediatr Emerg Care. 1985;1:198-200.
8. Epstein ML, Kiel EA, Victorica BE. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics. 1985;75:737-740.
9. Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg. 2008;107:1514-1522.
10. Chrysostomou C, De Toledo JS, Wearden P, etal. Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac surgery. Ann Thorac Surg. 2011;92:964-972.
11. Kamibayashi T, Hayashi Y, Mammoto T, Yamatodani A, Sumikawa K, Yoshiya I. Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology. 1995;83:992-999.
12. Lazol J, Lichtenstein S, Jooste E, etal. Effect of dexmedetomidine on pulmonary artery pressure after congenital cardiac surgery. Pediatr Crit Care Med. 2010;11:589-592.
13. Chrysostomou C, Sanchez de Toledo J, Avolio T, etal. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery? Pediatr Crit Care Med. 2009;10:654-660.
14. Chrysostomou C, Di Filippo S, Manrique AM, etal. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006;7:126-131.
15. Kleinman ME, de Caen AR, Chameides L, etal.; Pediatric Basic and Advanced Life Support Chapter Collaborators. Part 10: pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation. 2010;122(suppl 2):S466-S515.
16. DiMarco JP, Miles W, Akhtar M, etal. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil: assessment in placebo-controlled, multicenter trials. Ann Intern Med. 1990;113:104-110.
17. Ross CA, Ruggiero DA, Reis DJ. Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J Comp Neurol. 1985;242:511-534.
18. Robertson HA, Leslie RA. Noradrenergic alpha-2 binding sites in vagal dorsal motor nucleus and nucleus tractus solitarius: autoradiographic localization. Can J Physiol Pharmacol. 1985;63:1190-1194.
19. Chrysostomou C, Komarlu R, Lichtenstein S, etal. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med. 2010;36:836-842.
20. Hammer GB, Drover DR, Cao H, etal. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg. 2008;106:79-83.
21. Brodie P, Munoz R, Shiderly D, Chrysostomou C. Use of dexmedetomidine in sustained ventricular tachycardia. Anaesth Intensive Care. 2010;38:781.
22. Jaeggi E, Chiu C, Hamilton R, Gilljam T, Gow R. Adenosine-induced atrial pro-arrhythmia in children. Can J Cardiol. 1999;15:169-172.